Wecome Pharmaceutical announced that it has recently received the summary report of the phase IIb clinical trial of Silver and Huang Dropping Pills for the treatment of recurrent oral ulcers (upper hot syndrome), which includes multi-center, randomized, double-blind, and placebo-controlled studies on the effectiveness and safety.
维康药业：收到银黄滴丸Ⅱb期临床试验总结报告
Zhejiang Wecome Pharmaceutical: Received the summary report of the phase IIb clinical trial of Silver and Huang Dropping Pills.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.